JPND: Large scale analysis of OMICS data for drug-target finding in neurodegenerative diseases

JPND is launching this joint transnational call with the aim of improving the understanding of the complex and multifactorial pathogenesis of neurodegenerative diseases through multi-OMICS and Big Data approaches designed to find new drug targets and target biomarkers for the development of tailored and personalised treatment approaches.

Diseases included in this call are: 

• Alzheimer’s disease and other dementias
• Parkinson’s disease and PD‐related disorders
• Prion diseases
• Motor neuron diseases
• Huntington’s disease
• Spinocerebellar ataxia (SCA)
• Spinal muscular atrophy (SMA)

Teams should include at least 3 countries and 3 to 6 participants.

Israeli applicants should contact Chief Scientist of the Ministry of Health (Dr. Irit Alon) to review and approve submission prior to application. 

Pls. note that in most cases applicants may hold only one MOH grant at any given time. Please check eligibility.

Funding: €140,000 total for Israeli partner + €20,000 for coordination
Duration: 3 years

Research Authority due date: 26.2.23

Pre proposal due date: 7.3.23
Full proposal due date:  29.6.23